(Photodermatol Photoimmunol Photomed[TA])
2,145 results
  • Beyond UV: Visible Light and Pigmentation. [Review]
    Photodermatol Photoimmunol Photomed. 2026 Sep; 42(5):e70125.Ip E, Passeron T, Rodrigues MPP
  • CONCLUSIONS: This review establishes VL as a clinically significant driver of melasma and PIH pathogenesis. Standardising VL photoprotection metrics and integrating these into sunscreen development is essential. Incorporating VL protective strategies into treatment recommendations is critical to improving outcomes, particularly in darker skin individuals where disease burden is greatest and treatment most challenging.
  • Natural Agents for Preventing Skin Damage Induced by Visible Light: A Systematic Review of Preclinical and Clinical Evidence. [Systematic Review]
    Photodermatol Photoimmunol Photomed. 2026 Sep; 42(5):e70113.Rodríguez-Luna A, Zamarrón A, … González SPP
  • CONCLUSIONS: Overall, available evidence supports a protective role for selected natural compounds against VL-induced skin damage, particularly through antioxidant and anti-inflammatory mechanisms, with the strongest clinical evidence focusing on natural sources of polyphenols. Nevertheless, this review highlights the need for standardized phototesting protocols and well-designed clinical trials. Future research should focus on comparative efficacy, long-term safety, and integration of natural compounds into combined photoprotection strategies tailored to different skin phototypes.
  • Home Phototherapy for Psoriasis: Evidence and Implementation. [Review]
    Photodermatol Photoimmunol Photomed. 2026 Sep; 42(5):e70117.Ghanim D, Thomas LE, … Wu JJPP
  • CONCLUSIONS: Home phototherapy is safe and effective for appropriately selected patients with plaque or guttate psoriasis and represents an underutilized, cost-effective alternative to office-based care. This review identifies three gaps that must be addressed to realize its potential: absence of long-term UV exposure and skin cancer data, equity barriers that may paradoxically limit access for the patients who stand to benefit most, and uncharacterized safety risks of over-the-counter devices. Closing these gaps through prospective safety studies, equity-centered implementation, and regulatory oversight will be essential to establishing home phototherapy as a widely accessible, evidence-based standard of care.